2025 Outlook: Focus Is on Top Line - November 13, 2024
The top trend we are monitoring for 2025 is the impact that the burgeoning market for GLP-1 drugs has on the weight loss stocks.
Direct Sellers Valuation Update - Relative Valuations Remain at Generational Lows
The 12-month prospective relative P/E ratio for our proprietary Direct Selling Index closed 2023 at a 43% discount to the market, having entered...
2024 Trends for Direct Sellers - Looking for an Inflection Point
This year marks the fifth year in the most current downcycle for the stocks we monitor in the direct selling channel with the brief exception of...
Herbalife China in Transition: 2017 Review
2017 was a challenging year for Herbalife Ltd (HLF US) China, a market that generates ~30% of the entire company's revenue. The formal CEO Jerry...
No more insights